Evaluation of Clinical, Laboratory and Treatment Modalities in C3 Glomerulopathy: Single Center Experience
Yeter, H. Hasan, Sütiçen, Erdem, Korucu, Berfu, Helvaci, Özant, Özbaş, Burak, Gönül, İpek, Derici, Ülver, Arinsoy, Turgay, Güz, Galip
Prognostic factors in glomerular diseases with crescents
Yeter, Hasan Haci, Gonul, Ipek, Demirel, Ertugrul, Korucu, Berfu, Derici, Ulver
Discontinuation of Eculizumab treatment after hematological remission in patients with atypical and drug-induced hemolytic uremic syndrome
Yeter, Hasan H., Derici, Ulver, Arinsoy, Turgay, Altok, Kadriye, Erten, Yasemin, Guz, Galip
Combining clinical features and MEST-C score in IgA nephropathy may be a better determinant of kidney survival
Yeter, Hasan Haci, Gonul, Ipek, Guz, Gizem, Helvaci, Ozant, Korucu, Berfu, Akcay, Omer Faruk, Derici, Ulver, Arinsoy, Turgay